CARDINAL HEALTH, INC.

Lobbying for CARDINAL HEALTH INC

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Expenses

$1,070,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Ohio

Official filing document

Government bodies contacted 4

Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE
U.S. Trade Representative (USTR)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 5

Health Issues

Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health, food is medicine, acute hospital care at home waiver; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, pandemic preparedness, and product shortages.

Manufacturing

Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation bottlenecks.

Taxation/Internal Revenue Code

Issues related to tax reform and 2017 Tax Cuts and Jobs Act.

Trade (domestic/foreign)

Issues related to tariffs, trade, and U.S. trade policy.

Tariff (miscellaneous tariff bills)

Issues related to tariffs, trade, and U.S. trade policy.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.